-DOCSTART- -X- O
BACKGROUND -X- _ O
: -X- _ O
The -X- _ O
present -X- _ O
study -X- _ O
aims -X- _ O
to -X- _ O
assess -X- _ O
the -X- _ O
cost-effectiveness -X- _ O
of -X- _ O
an -X- _ O
influenza -X- _ B-Intervention
vaccination -X- _ I-Intervention
program -X- _ I-Intervention
for -X- _ O
children -X- _ B-Patient
in -X- _ I-Patient
the -X- _ I-Patient
Netherlands. -X- _ I-Patient
This -X- _ O
requires -X- _ O
an -X- _ O
evaluation -X- _ O
of -X- _ O
the -X- _ O
long-term -X- _ B-Comparison
impact -X- _ I-Comparison
of -X- _ I-Comparison
such -X- _ I-Comparison
a -X- _ I-Comparison
program -X- _ I-Comparison
on -X- _ I-Comparison
the -X- _ I-Comparison
burden -X- _ I-Comparison
of -X- _ I-Comparison
influenza -X- _ I-Comparison
across -X- _ I-Comparison
all -X- _ I-Comparison
age -X- _ I-Comparison
groups -X- _ I-Comparison
, -X- _ O
using -X- _ O
a -X- _ O
transmission -X- _ O
model -X- _ O
that -X- _ O
accounts -X- _ O
for -X- _ O
the -X- _ O
seasonal -X- _ O
variability -X- _ O
in -X- _ O
vaccine -X- _ O
effectiveness -X- _ O
and -X- _ O
the -X- _ O
shorter -X- _ O
duration -X- _ O
of -X- _ O
protection -X- _ O
following -X- _ O
vaccination -X- _ O
as -X- _ O
compared -X- _ O
to -X- _ O
natural -X- _ O
infection. -X- _ O
METHODS -X- _ O
: -X- _ O
We -X- _ O
performed -X- _ O
a -X- _ O
cost-effectiveness -X- _ B-Outcome
analysis -X- _ I-Outcome
based -X- _ I-Outcome
on -X- _ I-Outcome
a -X- _ I-Outcome
stochastic -X- _ I-Outcome
dynamic -X- _ I-Outcome
transmission -X- _ I-Outcome
model -X- _ I-Outcome
that -X- _ I-Outcome
has -X- _ I-Outcome
been -X- _ I-Outcome
calibrated -X- _ I-Outcome
to -X- _ I-Outcome
reported -X- _ I-Outcome
GP -X- _ I-Outcome
visits -X- _ I-Outcome
with -X- _ I-Outcome
influenza-like -X- _ I-Outcome
illness -X- _ I-Outcome
in -X- _ I-Outcome
the -X- _ I-Outcome
Netherlands -X- _ I-Outcome
over -X- _ I-Outcome
11 -X- _ I-Outcome
seasons -X- _ I-Outcome
( -X- _ I-Outcome
2003 -X- _ I-Outcome
/ -X- _ I-Outcome
2004 -X- _ I-Outcome
to -X- _ I-Outcome
2014 -X- _ I-Outcome
/ -X- _ I-Outcome
2015 -X- _ I-Outcome
) -X- _ I-Outcome
. -X- _ O
We -X- _ O
analyzed -X- _ O
the -X- _ O
costs -X- _ O
and -X- _ O
effects -X- _ O
of -X- _ O
extending -X- _ O
the -X- _ O
current -X- _ O
program -X- _ O
with -X- _ O
vaccination -X- _ O
of -X- _ O
children -X- _ O
aged -X- _ O
2–16 -X- _ O
years -X- _ O
at -X- _ O
50 -X- _ O
% -X- _ O
coverage -X- _ O
over -X- _ O
20 -X- _ O
consecutive -X- _ O
seasons. -X- _ O
We -X- _ O
measured -X- _ O
the -X- _ O
effects -X- _ O
in -X- _ O
quality-adjusted -X- _ O
life-years -X- _ O
( -X- _ O
QALYs -X- _ O
) -X- _ O
and -X- _ O
we -X- _ O
adopted -X- _ O
a -X- _ O
societal -X- _ O
perspective. -X- _ O
RESULTS -X- _ O
: -X- _ O
The -X- _ O
childhood -X- _ O
vaccination -X- _ O
program -X- _ O
is -X- _ O
estimated -X- _ O
to -X- _ O
have -X- _ O
an -X- _ O
average -X- _ O
incremental -X- _ O
cost-effectiveness -X- _ B-Outcome
ratio -X- _ I-Outcome
( -X- _ I-Outcome
ICER -X- _ I-Outcome
) -X- _ I-Outcome
of -X- _ I-Outcome
€3944 -X- _ I-Outcome
per -X- _ I-Outcome
QALY -X- _ I-Outcome
gained -X- _ I-Outcome
and -X- _ I-Outcome
is -X- _ I-Outcome
cost-effective -X- _ I-Outcome
in -X- _ I-Outcome
the -X- _ I-Outcome
general -X- _ I-Outcome
population -X- _ I-Outcome
( -X- _ I-Outcome
across -X- _ I-Outcome
1000 -X- _ I-Outcome
simulations -X- _ I-Outcome
; -X- _ I-Outcome
conventional -X- _ I-Outcome
Dutch -X- _ I-Outcome
threshold -X- _ I-Outcome
of -X- _ I-Outcome
€20,000 -X- _ I-Outcome
per -X- _ I-Outcome
QALY -X- _ I-Outcome
gained -X- _ I-Outcome
) -X- _ I-Outcome
. -X- _ O
The -X- _ O
childhood -X- _ B-Outcome
vaccination -X- _ I-Outcome
program -X- _ I-Outcome
is -X- _ I-Outcome
not -X- _ I-Outcome
estimated -X- _ I-Outcome
to -X- _ I-Outcome
be -X- _ I-Outcome
cost-effective -X- _ I-Outcome
for -X- _ I-Outcome
the -X- _ I-Outcome
target-group -X- _ I-Outcome
itself -X- _ I-Outcome
with -X- _ I-Outcome
an -X- _ I-Outcome
average -X- _ I-Outcome
ICER -X- _ I-Outcome
of -X- _ I-Outcome
€57,054 -X- _ I-Outcome
per -X- _ I-Outcome
QALY -X- _ I-Outcome
gained. -X- _ I-Outcome
Uncertainty -X- _ O
analyses -X- _ O
reveal -X- _ O
that -X- _ O
these -X- _ O
ICERs -X- _ O
hide -X- _ O
a -X- _ O
wide -X- _ O
range -X- _ O
of -X- _ O
outcomes. -X- _ O
Even -X- _ O
though -X- _ O
introduction -X- _ O
of -X- _ O
a -X- _ O
childhood -X- _ O
vaccination -X- _ O
program -X- _ O
decreases -X- _ O
the -X- _ O
number -X- _ O
of -X- _ O
infections -X- _ O
, -X- _ O
it -X- _ O
tends -X- _ O
to -X- _ O
lead -X- _ O
to -X- _ O
larger -X- _ O
epidemics -X- _ O
: -X- _ O
in -X- _ O
23.3 -X- _ O
% -X- _ O
of -X- _ O
1000 -X- _ O
simulations -X- _ O
, -X- _ O
the -X- _ O
childhood -X- _ O
vaccination -X- _ O
program -X- _ O
results -X- _ O
in -X- _ O
an -X- _ O
increase -X- _ O
in -X- _ O
seasons -X- _ O
with -X- _ O
a -X- _ O
symptomatic -X- _ O
attack -X- _ O
rate -X- _ O
larger -X- _ O
than -X- _ O
5 -X- _ O
% -X- _ O
, -X- _ O
which -X- _ O
is -X- _ O
expected -X- _ O
to -X- _ O
cause -X- _ O
serious -X- _ O
strain -X- _ O
on -X- _ O
the -X- _ O
health -X- _ O
care -X- _ O
system. -X- _ O
In -X- _ O
6.4 -X- _ O
% -X- _ O
of -X- _ O
1000 -X- _ O
simulations -X- _ O
, -X- _ O
the -X- _ O
childhood -X- _ O
vaccination -X- _ O
program -X- _ O
leads -X- _ O
to -X- _ O
a -X- _ O
net -X- _ O
loss -X- _ O
of -X- _ O
QALYs. -X- _ O
These -X- _ O
findings -X- _ O
are -X- _ O
robust -X- _ O
across -X- _ O
different -X- _ O
targeted -X- _ O
age -X- _ O
groups -X- _ O
and -X- _ O
vaccination -X- _ O
coverages. -X- _ O
CONCLUSIONS -X- _ O
: -X- _ O
Modeling -X- _ O
indicates -X- _ O
that -X- _ O
childhood -X- _ O
influenza -X- _ O
vaccination -X- _ O
is -X- _ O
cost-effective -X- _ O
in -X- _ O
the -X- _ O
Netherlands. -X- _ O
However -X- _ O
, -X- _ O
childhood -X- _ O
influenza -X- _ O
vaccination -X- _ O
is -X- _ O
not -X- _ O
cost-effective -X- _ O
when -X- _ O
only -X- _ O
outcomes -X- _ O
for -X- _ O
the -X- _ O
children -X- _ O
themselves -X- _ O
are -X- _ O
considered. -X- _ O
In -X- _ O
approximately -X- _ O
a -X- _ O
quarter -X- _ O
of -X- _ O
the -X- _ O
simulations -X- _ O
, -X- _ O
the -X- _ O
introduction -X- _ O
of -X- _ O
a -X- _ O
childhood -X- _ O
vaccination -X- _ O
program -X- _ O
increases -X- _ O
the -X- _ O
frequency -X- _ O
of -X- _ O
seasons -X- _ O
with -X- _ O
a -X- _ O
symptomatic -X- _ O
attack -X- _ O
rate -X- _ O
larger -X- _ O
than -X- _ O
5 -X- _ O
% -X- _ O
. -X- _ O
The -X- _ O
possibility -X- _ O
of -X- _ O
an -X- _ O
overall -X- _ O
health -X- _ O
loss -X- _ O
can -X- _ O
not -X- _ O
be -X- _ O
excluded -X- _ O
. -X- _ O

